The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
Abstract
The prelimbic medial prefrontal cortex (PL) is an important encephalic structure involved in the expression of emotional states. In a previous study, intra-PL injection of cannabidiol (CBD), a major non-psychotomimetic cannabinoid present in the Cannabis sativa plant, reduced the expression of fear conditioning response. Although its mechanism remains unclear, CBD can facilitate 5HT1A receptor-mediated neurotransmission when injected into several brain structures. This study was aimed at verifying if intra-PL CBD could also induce anxiolytic-like effect in a conceptually distinct animal model, the elevated plus maze (EPM). We also verified if CBD effects in the EPM and contextual fear conditioning test (CFC) depend on 5HT1A receptors and previous stressful experience. CBD induced opposite effects in the CFC and EPM, being anxiolytic and anxiogenic, respectively. Both responses were prevented by WAY100,635, a 5HT1A receptor antagonist. In animals that had been previously (24h) submitted to a stressful event (2h-restraint) CBD caused an anxiolytic, rather than anxiogenic, effect in the EPM. This anxiolytic response was abolished by previous injection of metyrapone, a glucocorticoid synthesis blocker. Moreover, restraint stress increased 5HT1A receptors expression in the dorsal raphe nucleus, an effect that was attenuated by injection of metyrapone before the restraint procedure. Taken together, these results suggest that CBD modulation of anxiety in the PL depend on 5HT1A-mediated neurotransmission and previous stressful experience.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The anxiolytic-like effects produced by CBD injections into the rat infralimbic (Marinho et al., 2015) or prelimbic (Fogaca et al., 2014) cortices, BNST (Gomes et al., 2013; Gomes et al., 2012; Gomes et al., 2011) and dPAG (Campos et al., 2013a) are attenuated by concomitant 5-HT1A-R antagonism.”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Fogaca et al., 2014
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
Diorio, D., Viau, V, & Meaney, M. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-09-03839.1993 · Cited by 1,151
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 978
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Marzo, V. D., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 879
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Repeated Stress Induces Dendritic Spine Loss in the Rat Medial Prefrontal Cortex
Radley, J. J., Rocher, A. B., Miller, M., Janssen, W. G. M., Liston, C., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhi104 · Cited by 820
Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771
Cited by
Sorted by citations
Items 101–152 of 152
Borges‐Assis, A. B., Uliana, D. L., Hott, S. C., Guimarães, F. S., Lisboa, S. F. D. S., & Resstel, L. B. M. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110739 · Cited by 11
Self-citationCannabidiol and 5-HT1A Receptors
Fogaça, M. V., Campos, A. C., & Guimarães, F. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00070-5 · Cited by 11
Self-citationAlmeida‐Santos, A. F., Moreira, F. A., Guimarães, F. S., & de Aguiar, D. C. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117704986 · Cited by 12
“Excitotoxic lesions of each of these areas induced anxiogeniclike effects (Jinks and McGregor, 1997), and the administration of the phytocannabinoid cannabidiol in the PL or IL induced an anxyolitic-like effect (Fogaca et al., 2014; Marinho et al., 2015).”
BackgroundSelf-citationMendiguren, A., Aostri, E., & Pineda, J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-61663-2_8 · Cited by 10
Fogaça, M. V., Fedoce, A. G., Ferreira‐Junior, N. C., Guimarães, F. S., & Resstel, L. B. M. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4228-7 · Cited by 10
“More recently, similar opposite effects were reported after intra-PL administration of the phytocannabinoid cannabidiol in the EPM and CFC (Fogaça et al. 2014).”
Self-citationCannabinoids: for better and for worse
Thibaut, F., & Hoehe, M. R. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/fthibaut · Cited by 7
Cannabidiol in anxiety disorders: Current and future perspectives
Simei, J. L. Q., Souza, J. D. R., Lisboa, J. R., Guimarães, F. S., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.003 · Cited by 7
Self-citationCannabidiol: Pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders
Lirio, P. H. C., Gaspari, P. D. M., & Campos, A. C. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.001 · Cited by 6
Self-citationOlatunji, S., Olubunmi, O. P., Abijo, A. Z., Oladele, O. J., Taiye, A. S., Ayodele, A., Fasesan, O., Afees, O. J., & Kayode, A. A. (2022) · Annals of Neurosciences · doi:10.1177/09727531221120988 · Cited by 5
CBD Versus CBDP: Comparing In Vitro Receptor-Binding Activities
Haghdoost, M., Young, S., Holloway, A. K., Roberts, M., Zvorsky, I. A., & Bonn‐Miller, M. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147724 · Cited by 5
Marchi-Coelho, C., Ferreira, W. C., Reis‐Silva, L. L., & Crestani, C. C. (2021) · Cells · doi:10.3390/cells10051217 · Cited by 5
“Similar effect was observed with medial prefrontal cortex treatment with the phytocannabinoid cannabidiol [60].”
ResultInfluentialTherapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.
Razavi, Y., Keyhanfar, F., Shabani, R., Haghparast, A., & Mehdizadeh, M. (2021) · PubMed Central · doi:10.22037/ijpr.2021.114918.15106 · Cited by 6
Alternative and Complimentary Medication Use in Singers: A Pilot Survey
Mavraj, G., Balouch, B., Alnouri, G., & Sataloff, R. T. (2022) · Journal of Voice · doi:10.1016/j.jvoice.2022.08.021 · Cited by 5
Are cannabidiol (CBD) levels in consumer food products well tested?—A review
Siddiqui, S. A., Fidan, H., Stankov, S., Mehdizadeh, M., Ambartsumov, T. G., Kharazmi, M., Singh, S., & Jafari, S. M. (2023) · Food Frontiers · doi:10.1002/fft2.308 · Cited by 5
Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats
Gom, R. C., Wickramarachchi, P., George, A. G., Lightfoot, S. H. M., Newton-Gunderson, D., Hill, M. N., Teskey, G. C., & Colangeli, R. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02005-y · Cited by 4
“Several preclinical and clinical studies report that CBD [9, 10], a relatively safe compound, might be an effective treatment for anxiety [11, 12], and for the negative emotional consequences associated with stress [11 – 13], drug use disorders [11, 14, 15], and neurodegenerative disorders [9, 16].”
The contribution of addictovigilance data to the French medical cannabis experimentation
Bouquet, É., Jouanjus, É., Pain, S., Batisse, A., Eiden, C., & Chevallier, C. (2024) · Therapies · doi:10.1016/j.therap.2024.10.060 · Cited by 4
da Silva, N. R., Gobbo, D., Gomes, F. V., Scheller, A., Kirchhoff, F., Bel, E. D., & Guimarães, F. S. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149772 · Cited by 4
Self-citationA Review of Recent Advances in the Therapeutic Uses of Secondary Cannabinoids
Morabito, D. M., Soyster, P. D., Ramey-Wright, S., Belendiuk, K. A., & Bonn‐Miller, M. O. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0096-9 · Cited by 4
Han, Y., Wang, S., Xiang, Y., Chang, L., Wang, X., Ren, S., Guo, F., Li, T., Liu, Z., & Li, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1431758 · Cited by 3
Anxiolytic and antidepressant effects of cannabidiol: a systematic review
Júnior, J. E. R. H., Barriga, J. R. D. M., Mesquita, D. D. S., & Pinto, J. P. (2021) · Journal of Health & Biological Sciences · doi:10.12662/2317-3076jhbs.v9i1.3366.p1-7.2021 · Cited by 3
Oral CBD-rich hemp extract modulates sterile inflammation in female and male rats
Hopkins, S., Kelley, T., Roller, R., Thompson, R. S., Colagiovanni, D. B., Chupka, K., & Fleshner, M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1112906 · Cited by 2
“There is emerging evidence from in vitro and in vivo preclinical studies that CBD has biological, stress-modulatory, and antiinflammatory properties (Malfait et al., 2000; Esposito et al., 2013; Li et al., 2013; Fogaça et al., 2014; Gallily et al., 2015; Elliott et al., 2018; Kim et al., 2022).”
BackgroundBadolato, C. J., Lynch, E. A., Arnold, J. C., McGregor, I. S., & Bowen, M. T. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70070 · Cited by 3
“Numerous animal studies subsequently confirmed the functional significance of CBD's 5-HT 1A R-mediated activity for reducing anxiety-(Fogaca et al., 2014), depression-(Linge et al., 2016), and stress-like (Campos et al., 2012) symptoms.”
Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease
Costa, C., Bellingacci, L., Canonichesi, J., Imperatore, V., Taddei, A. A., Zafra‐Puerta, L., Iglesias‐Cabeza, N., Prontera, P., Mancini, A., Filippo, M. D., et al. (2025) · Epilepsia · doi:10.1111/epi.70024 · Cited by 1
Cannabidiol in the context of sleeping disorders-induced oxidative stress
Jîtcă, G., Ősz, B. E., Rusz, C.-M., Puşcaş, A., Tero-Vescan, A., Bătrînu, M.-G., & Ștefănescu, R. (2022) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2022-0023 · Cited by 1
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_5 · Cited by 1
Efeitos do canabidiol no comportamento agressivo induzido por isolamento social em camundongos
dos Santos, A. H. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-20072016-151736 · Cited by 1
Freels, T. G., & Cook, M. N. (2016) · Psychology & Neuroscience · doi:10.1037/pne0000071 · Cited by 1
Examining associative and non-associative fear memories in the Rat Exposure Test
Fallon, K. (2017) · Memorial University Research Repository (Memorial University)
Efeitos comportamentais e neuroplásticos da combinação de escitalopram e canabinóides
Scarante, F. F. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-25072018-103829
Khan, A. U. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-29042019-162811
Fusse, E. J. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-23102019-162952 · Cited by 1
Manucha, W. A., Giménez, V. M. M., Marón, F. J. M., De, K., & Ferder, L. (2016) · Annals of Pharmacology and Pharmaceutics · doi:10.25107/2573-6051-v4-id1168
“However, CBD could cause a mild anxiolytic effect in animals subjected to a previous aversive stimulus [48,50,57].”
BackgroundVila-Verde, C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-08012020-105748
“Diversos estudos verificaram que os efeitos antiestresse e ansiolíticos do CBD parecem ser mediados por alterações no sistema serotoninérgico, possívelmente por facilitar a sinalização serotoninérgica via receptores 5HT-1A (Campos et al., 2012b; Gomes et al., 2012; Fogaça et al., 2014).”
Backgrounddos Santos, A. H. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-04012021-103831 · Cited by 1
Behavioural effects of cannabidiol in a preclinical model of neurodevelopmental disorders
Alam, T. (2018) · TSpace (University of Toronto)
Behavioural and molecular effects induced by Cannabidiol in animal models of depression
Silote, G. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2021.tde-29092021-060118
Tims, N. (2021) · Lancaster EPrints (Lancaster University) · doi:10.17635/lancaster/thesis/1438
de Assis, A. B. B. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-11042022-135852
Modulação da plasticidade sináptica por TREK-1 e 5HT>sub<1A>/sub< no estresse crônico pós-natal.
de Oliveira, J. F. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2020.tde-23092021-134813
Amaral, D. S. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2023.tde-08052023-105940
Sampaio, M. D. F. D. S., de Paiva, Y. B., Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2023) · doi:10.22541/au.169747457.78026237/v1
da Cruz, L. D. M. A., dos Santos, J. R. B., & Matheus, M. E. (2023) · Amplla Editora eBooks · doi:10.51859/amplla.ame553.1123-0
Cannabidiol, a promising therapy for post-traumatic stress disorder and depression. A mini-review
Jîtcă, G. (2024) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2024-0012
The chemistry and pharmacology of tetrahydrocannabinol and cannabidiol
Jana, C. E., Mwambyale, T., Chirambo, G., Gwedela, M. N. V., Chimphepo, L., & Chikowe, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95927-8.00019-0
Canabidiol, ansiedade e memórias aversivas: uma revisão das evidências pré-clínicas
Portes, M. A. M., Werle, I., Soares, L. A., Guterres, F. D. S., & Bertoglio, L. J. (2025) · Revista Fitos · doi:10.32712/2446-4775.2025.1817
Jones, M. J., Uzuneser, T. C., O’Sullivan, S. E., Pérez-Valenzuela, E., Sarikahya, M. H., Yates, A., Hardy, D. B., Rushlow, W. J., & Laviolette, S. R. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111478
Emerging Therapeutic Approaches and Drugs for Anxiety and Related Disorders
Kumar, V., Nahari, S. T. M. A. A., Singh, S. K., Kumar, A., Wadhwa, P. K., Duggal, N., & Tewari, D. (2025) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_47_25
Boury‐Esnault, N., Marschal, C., Probst, J.-M. K., & Barnathan, G. (2002) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.155630
Alvarenga, I. C., Hess, H., Fagen, A., Feldman, A., Wilson, K., Wernimont, S. M., & McGrath, S. (2026) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2025.12.012
Jantsch, J., Wickert, F., Fraga, G. D. F., de Fraga, L. S., Durán‐Carabali, L. E., & Guedes, R. P. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03733-x
“Despite this, behavioral effects can be more pronounced in males, indicating that differences in biological sensitivity to CBD may underlie these fi ndings [27].”
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_5
Lima, T. S. A., Verza, F. A., Godoy, L. D., Guimarães, F. S., & Gomes, F. V. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111981
Self-citation
Metadata
- Authors
- Fogaça, M. V., Reis, F. M. C. V., Campos, A. C., & Guimarães, F. S.
- Affiliations
- Universidade de São Paulo (BR)
- Universidade Federal de Minas Gerais (BR)
- Corresponding author
- Fogaça, M.V.
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 24
- Issue
- 3
- Pages
- 410-419
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W1975839888
- Semantic Scholar
- 520a9e101f0113f63d37c6bb694ef23f93512fe6
- Cited by
- 153
- References
- 52
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 12 · 2021: 24 · 2020: 16 · 2019: 16 · 2018: 10 · 2017: 17 · 2016: 12 · 2015: 9 · 2014: 2
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- cannabidiol, anxiety-like behavior, 5-HT1A receptor, restraint stress, anxiolytic effects, anxiogenic effects, dorsal raphe nucleus, metyrapone, glucocorticoid synthesis, WAY-100635, contextual fear conditioning, elevated plus maze
- MeSH terms
- Animals, Anxiety, Cannabidiol, Conditioning, Psychological, Dose-Response Relationship, Drug, Enzyme Inhibitors, Exploratory Behavior, Fear, Male, Metyrapone, Piperazines, Pyridines, Raphe Nuclei, Restraint, Physical, Stress, Psychological, Time Factors, Anti-Anxiety Agents, Rats, Wistar, Prefrontal Cortex, Maze Learning, Receptor, Serotonin, 5-HT1A, Serotonin 5-HT1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review